Abstract: The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one DNA, RNA or bioactive agent characterized with a positive surface charge and their enhanced efficiency for gene delivery and bioactive agent delivery.
Type:
Grant
Filed:
September 8, 2010
Date of Patent:
June 11, 2013
Assignees:
GP Medical, Inc., National Tsing Hu University